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The effects of oral pregabalin on 
post‑operative pain of lower limb 
orthopedic surgery: A double‑blind, 
placebo‑controlled trial
preventing from complications such as tachycardia, 
hypertension, myocardial ischemia, decreased alveolar 
ventilation, and poor wound healing is of  special 
importance. Exacerbation of  acute pain may lead 
to increased sensitivity in neurons and releasing 
central and peripheral mediators. Advances in the 
molecular mechanisms has led to the development of  
multidimensional analgesia and using new pharmaceutical 
products on post‑operative pain control,[1] and pregabalin 
is one of  these new products. Acute pain after surgery has 
been as predictor of  persistent pain after surgery and about 
5‑50% of  patients experience persistent post‑operative 
pain in different varieties of  surgical operations.[2] Recent 
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Abstract
Original Article
Background: Post‑operative pain is one of the problems, wherein lack of control on it has 
many side‑effects such as tachycardia, hypertension, myocardial ischemia, decreased alveolar 
ventilation, and poor wound healing. Aims: In this study, we evaluated the pre‑operative 
administration of pregabalin sufficiency and security in relieving post‑operative pain after 
lower limb orthopedic surgery and reducing the need for opioids and their possible side‑effects. 
Materials and Methods: This study is a randomized, double‑blind clinical trial. It was 
performed on 60 patients under lower limb surgery by spinal anesthesia. Patients were randomly 
allocated to two groups, one group has received a 150 mg pregabalin capsule 2 h before surgery 
and the other group has received placebo as a control. In both groups at 2, 6, 12, and 24 h 
after surgery, the patients were evaluated and the pain score, the score of sedation, incidence 
of nausea and vomiting was recorded in the checklists. Then, the data were analyzed by SPSS 
v16. Results: Visual analog pain scores at all hours in pregabalin group significantly reduced 
compared to the placebo group (P < 0.0001). Also, in the pregabalin group nausea and vomiting 
scores at all hours, sedation levels at 2 h and 6 h post‑operatively, and pethidine consumption 
in all hours have significantly been reduced. Conclusion: A single pre‑operative oral dose 
of pregabalin 150 mg is an effective method for reducing post‑operative pain and pethidine 
consumption in patients undergoing orthopedic surgery.
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INTRODUCTION
Post‑operative pain is among the problems, which lack 
of  adequate control on it has many complications. 
Post‑operative appropriate pain control in terms of  
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advances in the pathophysiology of  pain have provided 
the possibility of  prevention or reduction of  excessive 
excitability of  the central nervous system (CNS) associated 
with post‑operative intensified pain.[3] Pregabalin is 
a new synthetic molecule derived from inhibitor for 
the neurotransmitter gamma‑amino butyric acid. This 
medicine is δ‑2 α ligand having anesthetic, anticonvulsant, 
anti‑excitement, and sleep movement moderating 
effects. Pregabalin has been effective in the treatment of  
neuropathic pain, incisional pain, and inflammatory pain 
and pains induced by formalin. Pregabalin plays its role 
in treatment of  acute post‑operative pain by decreasing 
the excitability of  dorsal horn neurons caused by tissue 
damage.[4] Moreover, since most patients are afflicted with 
stress and emotion pre‑operatively, the anti‑excitement 
effects of  pregabalin can be effective.[5] In several studies, 
pregabalin has been used to reduce the need for opioids,[6] 
treatment of  dental pains,[7] the treatment of  pain after 
spinal fusion surgery,[8] and treatment of  pain after 
laparoscopic cholecystectomy.[9‑14]
In this study, we investigated pre‑operatively prescribing 
pregabalin effectiveness and harmlessness in reducing 
pain after lower limb orthopedic surgery, and reduction 
of  pethidine consumption and possible complications.
MATERIALS AND METHODS
This prospective, randomized, double‑blind, and placebo 
controlled clinical study was designed to include 60 adult 
patients (20‑60 years) of  either sex, American Society 
of  Anesthesiologists (ASA) physical status I and II, 
undergoing lower limb surgery under spinal anesthesia in 
Fatemi Hospital of  Ardabil Medical Science University. 
The study protocol was approved from the institutional 
ethical committee and is registered at clinicaltrials.
gov database (Reference No. IRCT201212254093N5). 
The written informed consent was obtained from all 
participants.
Patients with pregnancy, neurological disease, psychiatric 
disorders, history of  seizures, acute or chronic renal disease, 
history of  peptic ulcer, history of  allergy to pregabalin 
or pethidine, taking psychotropic drugs, alcohol or drugs 
abuse, and daily intake of  analgesics were excluded from 
the study.
Patients meeting the inclusion criteria during the pre‑ 
anesthetic evaluation were randomly assigned into 
two groups of  30 each by using a computer‑generated 
table of  random numbers, to receive either a matching 
placebo (capsules of  similar appearance, but lacking the 
active ingredient of  the drug) or pregabalin 150 mg.
The medicine was administered orally approximately 2 h 
before induction of  anesthesia by a staff  nurse who was 
not involved in the study and no other premedication were 
permitted. None of  anesthesiologist, data assessor and data 
analyzer was aware of  the group assignment.
The patients were taken to the operating room and were 
equally induced by spinal anesthesia with 12‑15 mg of  
Bupivacaine 0.5% injected into the L4‑L5 space by using 
25‑gauge needle and the surgery was performed.
In this study, primary outcomes were severity of  
post‑operative pain, post‑operative pethidine requirement 
and sedation. Secondary outcomes were incidence of  
post‑operative nausea and vomiting (PONV). These 
outcomes were assessed by an anesthesiologist blinded 
to group allocation. Assessment of  pain was done by 
a 100 mm visual analogue scale (VAS); 0, no pain; 100, 
worst imaginable pain. Assessment of  pain was done at 
2, 6, 12, and 24 h after operation. The Ramsay sedation 
scale (awake levels were: (1) anxious, agitated, or restless; 
(2) cooperative, oriented, and tranquil; (3) responds to 
command; asleep levels were dependent on patient’s 
response to a light glabellar tap or loud auditory stimulus; 
(4) brisk response; (5) a sluggish response; and 6, no 
response) was used to assess the sedation; patients with a 
sedation scale of >4 were considered as sedated.[15]
In the recovery room, patients were given boluses of  
50 mg of  pethidine, based on an age‑stratified IV analgesia 
protocol, if  the pain score was ≥3.
Calculation of  sample size was based on the presumption 
that post‑operative VAS scores after pre‑operative 
administration of  pregabalin 150 mg could be reduced 
15 mm compared the placebo group at all‑time points. For 
the results to be of  statistical significance with α = 0.05 and 
β = 0.8, was calculated to 26 patients in each group. To take 
care of  any drop outs, we enrolled 30 patients in each group.
The data was analyzed using SPSS v. 16 by one‑way 
analysis of  variance (ANOVA) statistical tests and t‑test for 
quantitative variables and Chi‑square for qualitative ones. 
P < 0.05 was considered significant.
RESULTS
There was no substantial difference among the groups with 
regard to age, sex, duration of  surgery (P > 0.05) [Table 1].
In addition, the type of  fracture in patients was determined 
in each group. In both groups, the most common type of  
fracture was femur fracture, and in terms of  fracture type 
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there was no significant difference between the two groups’ 
patients (P > 0.05).
Average pain scores (VAS) at 2,6,12 and 24 h after surgery 
in pregabalin group was significantly lower than placebo 
group [Table 2]. The use of  pethidine as post‑operative 
analgesic is also significantly lower in pregabalin group than 
placebo [Table 2]. The incidence of  nausea and vomiting 
in 2, 6, 12, and 24 h after the operation were different 
among the groups [Table 3]. No significant difference was 
between the groups in terms of  sedation in 12 and 24 h 
after operation. However, this rate in the hours 2 and 6 
was significantly lower in pregabalin group than the control 
group [Table 4].
It wasn’t observed any other adverse events such as 
dizziness, headache, and visual disturbance in patients of  
both groups.
DISCUSSION
In this study, we observed that pre‑operative pregabalin 
(150 mg) was effective in reducing of  post‑operative 
pain along with post‑operative pethidine consumption in 
subjects undergoing lower limb orthopedic surgery.
Experimental models of  neuropathic and inflammatory 
pain have shown that amino butyric acid analogues 
such as gabapentin and pregabalin contain analgesic 
components and anti‑nociceptive. It is suspected, 
that CNS sensitivity may lead to post‑operative pain 
growth.[16] Administering gabapentin before surgery, 
before inflammatory trauma, or surgical stimulation 
may reduce the degree of  sensitivity of  the CNS.[17] In 
contrast to gabapentin, pregabalin which is an alternative 
to increase its solubility in fat and causes permeability in 
the blood‑brain barrier, include better pharmacokinetic 
properties and due to lack of  hepatic metabolism has 
less drug interactions.
In this study, the patients were assessed in terms of  PONV 
incidence rate and sedation score during the 24 h after 
surgery. In pregabalin group, PONV incidence rate, as well 
as the sedation score was lower than the control group. In 
several studies the presence of  complications among the 
patients are different. So that in Hill study[7] on the patients 
who had surgery on their teeth, and in Paech et al. study[18] 
who administered the drug after gynecologic surgeries, 
some complications such as vomiting, nausea, and 
abdominal pain were higher in pregabalin group while in the 
study of  Agarwal[12] on patients undergoing laparoscopic 
cholecystectomy, and in Mathiesen et al. study[19] on patients 
who had undergone hysterectomy these complications were 
lower in pregabalin group.
In this study, the pain severity was determined based 
on VAS score and it was found that pregabalin could 
significantly reduce the mean score of  pain in patients. 
The majority of  previous studies have similar results. 
For example, in Hill,[7] Agarwal et al.,[12] and Schulmeyer 
et al.[20] studies the post‑operative pain severity was 
Table 1: Demographic characteristics in two groups
Variable Pregabalin Placebo P value
Age (year) 43.66±12.17 41.93±11.39 0.58
Sex (m/f) 14/16 17/13 0.32
Duration of surgery (m) 93.58±31.32 101.36±36.14 0.14
Values have expressed as mean±SD
Table 2: Mean visual analogue scale score and 
mean pethidine consumption during 24 h after 
surgery
Variable Pregabalin Placebo P value
Mean VAS score
2 h after surgery 8.03±0.19 9.93±0.04 0.0001
6 h after surgery 6.06±0.21 9.13±0.11 0.0001
12 h after surgery 4.23±0.17 7.72±0.17 0.0001
24 h after surgery 2.56±0.14 5.73±0.15 0.0001
Mean pethidine
consumption (mg)
2 h after surgery 15.12±4.27 48.52±2.34 0.0001
6 h after surgery 8.43±3.59 46.61±2.35 0.001
12 h after surgery 5.15±2.91 38.81±3.62 0.0001
24 h after surgery 3.12±2.68 12.11±3.88 0.03
VAS=Visual analogue scale, values have expressed as mean±SD
Table 3: Incidence of post‑operative nausea and 
vomiting during 24 h after surgery
Variable Pregabalin Placebo P value
Incidence of PONV (%)
2 h after surgery 8 (27) 15 (50) 0.005
6 h after surgery 5 (17) 26 (87) 0.001
12 h after surgery 3 (10) 26 (87) 0.001
24 h after surgery 3 (10) 15 (50) 0.002
PONV=Post‑operative nausea and vomiting
Table 4: Sedation score of patients during 24 h after surgery
Sedation score Hour Pregabalin Placebo P value
0 1 2 3 ≥4 0 1 2 3 ≥4
2 h after surgery 0 15 10 5 0 2 4 15 9 0 0.0001
6 h after surgery 0 7 19 4 0 0 18 8 4 0 0.021
12 h after surgery 0 16 7 7 0 0 13 14 3 0 0.391
24 h after surgery 0 22 4 4 0 0 5 24 1 0 0.721
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reduced as a result of  consuming pregabalin while in 
other studies, including Paech et al.,[18] Jokela et al.[21] and 
Mathiesen et al.[19] it was found that the group using 
pregabalin had the same post‑operative pain intensity as 
the control group. One aspect observed in many studies 
on this drug is reduced post‑operative opioid and analgesic 
consumption in the pregabalin group. In Zhang et al.[6] study 
in 2011, he indicated that pregabalin significantly reduced 
post‑operative opioid consumption rate in patients. He 
also showed that pregabalin consumption can reduce some 
opioid side effects such as nausea and vomiting. Durkin 
et al.[9] showed in their study pregabalin consumption 
reduces opioid consumption in patients with chronic 
neuropathic pains. Additionally, Post et al.[10] observed that 
the use of  pregabalin reduced the opioid consumption 
after hip arthroplasty surgical operation. Our results were 
consistent with these studies.
CONCLUSION
A single pre‑operative oral dose of  pregabalin 150 mg 
is an effective method for reducing post‑operative 
pain in patients undergoing orthopedic surgery. The 
peri‑operative administration of  pregabalin has a 
significant opioid‑sparing effect in the first 24 h after 
surgery. PONV and sedation score was reduced with 
pregabalin administration.
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